Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns naming Niall Redmond .
Filed returns
71
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| May–Aug 2026 | Roche | Health | Revisions to the EU Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) legislative frameworks in the context of Ireland’s H2 2026 Presidency of the Council of the European Union. (Legislation) | 5 | On lobbying.ie |
| May–Aug 2026 | Roche | Economic Development and Industry | Progression and refinement of legislative proposals within the EU Biotech Act during Ireland’s H2 2026 Presidency of the Council of the European Union. (Public policy or programme) | 5 | On lobbying.ie |
| May–Aug 2026 | Roche | Economic Development and Industry | Quantitative target-setting and governance structures for Ireland’s National Life Science Strategy. (Public policy or programme) | 9 | On lobbying.ie |
| May–Aug 2026 | Alliance of Medicines for Ireland Company Limited by Guarantee | Health | Correspondence to Mr. Niall Redmond in relation to MFI'S EU Presidency Event (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2026 | Irish Pharmacy Union | Health | PSPPA Pharmacy Fee Review (Legislation) | 1 | On lobbying.ie |
| May–Aug 2026 | Irish Kidney Association | Health | Pre-budget submission advocating for i)Kidney Disease Registry; ii)Screening for CKD (early detection; iii)Primary Care Clinical Lead to drive CKD management; iv)commitment to a living donor transplantation target (Matters involving public funds) | 10 | On lobbying.ie |
| May–Aug 2026 | Irish Kidney Association | Health | Pre-budget submission advocating for i)Kidney Disease Registry; ii)Screening for CKD (early detection; iii)Primary Care Clinical Lead to drive CKD management; iv)commitment to a living donor transplantation target (Matters involving public funds) | 9 | On lobbying.ie |
| May–Aug 2026 | Takeda Products Ireland | Health | Engagements on life-sciences policy, innovation and competitiveness in Ireland and Europe (Public policy or programme) | 12 | On lobbying.ie |
| May–Aug 2026 | Abbott | Health | Deployment of FreeStyle Libre for people with diabetes (Matters involving public funds) | 3 | On lobbying.ie |
| May–Aug 2026 | Irish Pharmaceutical Healthcare Association | Health | EU Presidency Associated event with Commission VarHelyi on European Competitiveness and the role of Life Sciences and the Pharmaceutical Industry. (Public policy or programme) | 7 | On lobbying.ie |
| May–Aug 2026 | NCBI | Health | Assistive technology for people who are blind or vision impaired. (Public policy or programme) | 7 | On lobbying.ie |
| May–Aug 2026 | Vulcan Consulting Limited | Health | Rare Disease Policy in Ireland (Public policy or programme) | 14 | On lobbying.ie |
| May–Aug 2026 | Janssen Sciences Ireland UC | Health | Engagement with the Departments of Health and Enterprise regarding the national life science strategy (Public policy or programme) | 5 | On lobbying.ie |
| May–Aug 2026 | Ibec | Economic Development and Industry | Inter-Ministerial Meeting convened in Royal College of Physicians (Public policy or programme) | 6 | On lobbying.ie |
| May–Aug 2026 | Irish Platform for Patients' Organisations, Science and Industry | Health | Early access to medicines - IPPOSI wrote to the Minister for Health setting out the organisation's position on early access to medicines. The letter was also forwarded in parallel to key ministerial advisers, a relevant… (Public policy or programme) | 5 | On lobbying.ie |
| May–Aug 2026 | MSD | Economic Development and Industry | Government policy event relating to Ireland's life sciences sector (Public policy or programme) | 4 | On lobbying.ie |
| Jan–Apr 2026 | Janssen Sciences Ireland UC | Health | Meeting with Department of Health (Public policy or programme) | 3 | On lobbying.ie |
| Jan–Apr 2026 | Alliance of Medicines for Ireland Company Limited by Guarantee | Health | Engagement with officials in relation to the Framework Agreement on the Supply and Pricing of Medicines (Public policy or programme) | 3 | On lobbying.ie |
| Jan–Apr 2026 | Alliance of Medicines for Ireland Company Limited by Guarantee | Health | Correspondence to relevant stakeholders regarding possible supply chain disruption (Public policy or programme) | 4 | On lobbying.ie |
| Jan–Apr 2026 | Irish Pharmaceutical Healthcare Association | Health | Concluding text of Framework Agreement on Pricing and Supply of Medicines 2026-2029. (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2026 | Reckitt | Health | HPRA formal regulatory procedure to determine the appropriate method of sale for authorised codeine-containing medicines in Ireland (Public policy or programme) | 9 | On lobbying.ie |
| Jan–Apr 2026 | Abbott | Health | Deployment of FreeStyle Libre for people with diabetes (Matters involving public funds) | 2 | On lobbying.ie |
| Jan–Apr 2026 | Irish Dental Hygienist Association | Health | The Irish Dental Hygienist Association (IDHA) are Lobbying To Amend The Dental Act,1985 to remove: Section 54 (2) “Dental work carried out by an auxiliary dental worker in accordance with a scheme made by the Council… (Legislation) | 7 | On lobbying.ie |
| Jan–Apr 2026 | Consilient Health Limited | Health | pharmacy prescribing (Public policy or programme) | 3 | On lobbying.ie |
| Sep–Dec 2025 | Alliance of Medicines for Ireland Company Limited by Guarantee | Health | Engagement with officials in relation to the Framework Agreement on the Supply and Pricing of Medicines (Public policy or programme) | 3 | On lobbying.ie |
| Sep–Dec 2025 | Irish Pharmaceutical Healthcare Association | Health | New framework Agreement on the Pricing and Supply of Medicines. (Matters involving public funds) | 4 | On lobbying.ie |
| Sep–Dec 2025 | Irish Pharmaceutical Healthcare Association | Health | New framework Agreement on the Pricing and Supply of Medicines. (Public policy or programme) | 4 | On lobbying.ie |
| Sep–Dec 2025 | Irish Pharmaceutical Healthcare Association | Health | US-EU Trade Tariffs (Public policy or programme) | 3 | On lobbying.ie |
| Sep–Dec 2025 | Abbott | Health | Deployment of FreeStyle Libre for people with diabetes (Matters involving public funds) | 2 | On lobbying.ie |
| Sep–Dec 2025 | Consilient Health Limited | Health | pharmacy prescribing (Public policy or programme) | 3 | On lobbying.ie |
| May–Aug 2025 | Irish Pharmaceutical Healthcare Association | Health | Future Framework Agreement (Matters involving public funds) | 3 | On lobbying.ie |
| May–Aug 2025 | Alliance of Medicines for Ireland Company Limited by Guarantee | Health | Meeting with relevant Departmental stakeholders regarding a new Framework Agreement for the Pricing and Supply of Medicines. (Public policy or programme) | 3 | On lobbying.ie |
| May–Aug 2025 | Irish Pharmaceutical Healthcare Association | Health | Future Framework Agreement (Legislation) | 6 | On lobbying.ie |
| May–Aug 2025 | Irish Pharmaceutical Healthcare Association | Health | Future Framework Agreement (Legislation) | 3 | On lobbying.ie |
| May–Aug 2025 | Irish Pharmacy Union | Health | Pharmacy Service Reform and Fee Modernisation- Discussions on a Framework Agreement (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2025 | NCBI | Health | Aids and appliances for visual impairment (Public policy or programme) | 4 | On lobbying.ie |
| May–Aug 2025 | Pinnacle Public Affairs Ltd | Health | To engage with key stakeholders on funding for oral health prevention schemes in Budget 2026 (Matters involving public funds) | 10 | On lobbying.ie |
| May–Aug 2025 | Ibec | Health | National Clinical Trials Office (Public policy or programme) | 4 | On lobbying.ie |
| May–Aug 2025 | MSD | Health | Implementing an Early Access Scheme in Ireland (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2025 | Irish Pharmaceutical Healthcare Association | Health | Issues concerning the timely reimbursement of medicines in Ireland. (Public policy or programme) | 12 | On lobbying.ie |
| Jan–Apr 2025 | Irish Pharmacy Union | Health | Meeting with the Minister for Health and Officials (Legislation) | 3 | On lobbying.ie |
| Jan–Apr 2025 | Irish Pharmacy Union | Health | Free HRT Arrangement (Legislation) | 2 | On lobbying.ie |
| Jan–Apr 2025 | Irish Pharmacy Union | Health | Engagement Framework (Matters involving public funds) | 1 | On lobbying.ie |
| Jan–Apr 2025 | Alliance of Medicines for Ireland Company Limited by Guarantee | Health | Correspondence to Niall Redmond regarding Framework negotiations on the pricing and supply of medicines. (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2025 | Alliance of Medicines for Ireland Company Limited by Guarantee | Health | Correspondence to relevant stakeholders regarding the implications of the Urban Waste Water Treatment Directive. (Public policy or programme) | 22 | On lobbying.ie |
| Jan–Apr 2025 | Alliance of Medicines for Ireland Company Limited by Guarantee | Health | Correspondence to relevant stakeholders regarding MFI event 'Digital Solutions for a Greener Industry'. (Public policy or programme) | 13 | On lobbying.ie |
| Jan–Apr 2025 | Ibec | Economic Development and Industry | Retaliatory Tariffs: Impact on healthcare in Europe (Public policy or programme) | 11 | On lobbying.ie |
| Sep–Dec 2024 | Irish Pharmacy Union | Health | Formal Structured Engagement Process on Pay Talks (Matters involving public funds) | 3 | On lobbying.ie |
| Sep–Dec 2024 | Irish Pharmacy Union | Health | Free HRT Scheme (Matters involving public funds) | 3 | On lobbying.ie |
| Sep–Dec 2024 | Irish Pharmacy Union | Health | Pay Talks and HRT Scheme (Matters involving public funds) | 3 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 64 | 90.1% | |
| Economic Development and Industry | 5 | 7.0% | |
| EU Affairs | 2 | 2.8% |